8 min read
The difference between a diagnosis at stage one and a diagnosis at stage four is not just a medical distinction. It is the difference between a 91% five-year survival rate and a 15% one. In Ghana, most women are still diagnosed at the wrong end of that spectrum—and that is why early detection is not just a health message. It is a survival strategy.
The Stark Reality: Late Diagnosis Is the Norm
The numbers from Ghana’s leading referral hospitals paint a troubling picture.
Key Takeaways
- A study at Komfo Anokye Teaching Hospital (KATH), Ghana's second-largest tertiary hospital, found that only 10.3% of patients undergoing staging were diagnosed with early breast cancer (stage I or II).
- Early-stage disease often requires less aggressive treatment, fewer hospital visits, and lower financial burden on families already stretched by out-of-pocket healthcare costs.
- Only 18.5% of patients with confirmed breast cancer completed recommended treatment without abandonment .
A study at Komfo Anokye Teaching Hospital (KATH), Ghana’s second-largest tertiary hospital, found that only 10.3% of patients undergoing staging were diagnosed with early breast cancer (stage I or II). Half were diagnosed at stage III, and 39.3% at stage IV . A separate multi-region analysis found that most patients present with stage III disease (47.2%) .
The average duration of symptoms before presentation in Ghana is 10 months . By the time many women seek care, the disease has had months to progress.
The consequence is visible in the survival data. A 2026 meta-analysis synthesizing data from 2,114 patients across Ghana found a pooled median overall survival of 4.4 years and an estimated 5-year survival rate of 46.5% . For comparison, the American Cancer Society reports 5-year survival rates of over 99% for stage I disease .
The gap is not about biology. It is about timing.
The Survival Difference: Stage by Stage
The evidence from Ghanaian hospitals is unambiguous about what stage at diagnosis means for survival.
A study by Mensah et al. cited in Ghanaian medical literature showed 5-year cumulative survival rates of 91% for stage 0 and I disease, dropping to 60% for stage II, 34% for stage III, and just 15% for stage IV .
When diagnosed at early stages, breast cancer treatment is also most effective, best tolerated, and least costly . Early-stage disease often requires less aggressive treatment, fewer hospital visits, and lower financial burden on families already stretched by out-of-pocket healthcare costs.
The Global Breast Cancer Initiative (GBCI) has set a target of diagnosing at least 60% of cases at an early stage . Ghana is currently at 10.3%. The distance between those two figures represents thousands of lives that could be saved.
Why Women Present Late
The reasons women in Ghana present late are not mysterious. They are well-documented and deeply rooted in social, cultural, and economic realities.
Misconceptions about causation. Research at Ho Teaching Hospital found that misconceptions linking breast cancer to curses and spiritual attacks contributed to delays and reluctance toward biomedical treatment . A survey of 914 rural women found that 73.5% held misconceptions, including beliefs that breast cancer is transmissible or spiritually caused .
Fear and stigma. Community stigma compounds psychological distress. Women diagnosed with cancer are sometimes seen as “cursed,” which negatively impacts self-image and discourages others from seeking screening . Fear of a positive diagnosis itself is a barrier .
Limited knowledge of symptoms. Only 41.9% of rural women surveyed could recognise key warning signs, and even fewer understood risk factors . While most women have heard of breast cancer, knowledge about what to look for remains shallow.
Cost and access. Although the NHIS covers chemotherapy and radiotherapy, the larger financial burden of breast cancer care is borne by patients . Transportation, accommodation, and non-covered services create barriers that prevent women from following through on referrals.
Cultural and religious factors. For some communities, cultural norms around modesty and decision-making power can limit women’s access to screening and care . Fear of unmet cultural preferences at screening centres was identified as a barrier to clinical breast cancer screening among Islamic women in Kumasi.
The Diagnostic and Treatment Gap
Even when women do present, the system does not always hold them.
Ghana performs well on timely diagnosis—the GBCI target of confirming diagnosis within 60 days of first presentation. At KATH, all patients received their cancer diagnosis within 31 days, and 95% had biopsies performed within 21 days . This is a genuine achievement.
But the system falls short on treatment completion. Only 18.5% of patients with confirmed breast cancer completed recommended treatment without abandonment . This falls far short of the GBCI benchmark of over 80%.
The reasons are familiar. The reported average availability of cancer medicines in Ghanaian public hospitals is 14%, far below the WHO target of 80%. When NHIS-approved drugs run out of stock, patients must pay out-of-pocket. Up to 86% of patients with cancer at KATH are reported as unable to complete adjuvant treatment without interruption or abandonment .
Incomplete treatment leads to poorer outcomes. Among patients initiating recommended treatment at KATH, 93.3% of those who died had not completed treatment, while 72.3% of those alive had completed it . The correlation is stark.
What Early Detection Requires
Early detection is not a single intervention. It is a chain of actions, each of which must work.
Awareness that leads to action. Knowing about breast cancer is not the same as knowing what to do. The gap between awareness (87.5%) and adequate knowledge of symptoms (46.3%) must be closed through culturally tailored education that addresses misconceptions directly.
Accessible screening. Clinical breast examination and mammography must be available beyond tertiary centres. The NHIA has added breast screening to the Free Primary Healthcare package, a significant step . But implementation gaps remain, and screening must reach district and community levels where most women first interact with the health system .
Rapid referral and diagnosis. The diagnostic pathway must function without delays. Ghana has demonstrated it can confirm diagnoses quickly when systems are in place. This capacity must be extended beyond KATH and Korle Bu.
Treatment that is completed. Diagnosis without treatment is not early detection—it is early awareness of a problem that will not be solved. The availability of cancer medicines must improve, and financial barriers to completion must be removed.
Community engagement. Religious leaders, traditional healers, and community influencers shape health-seeking behaviour. Engaging them as partners in education and referral can address the spiritual and cultural beliefs that delay presentation .
The Cost of Waiting
The financial argument for early detection is as compelling as the survival argument.
Late-stage cancer treatment is more expensive—for families and for the health system. It requires more aggressive therapies, longer hospital stays, and more frequent interventions. When patients abandon treatment because they cannot afford it, the investment in diagnosis is wasted, and the disease progresses.
The GBCI’s goal is a 2.5% annual reduction in breast cancer mortality . Achieving that goal requires moving the proportion of early-stage diagnoses from 10.3% toward 60%. Every percentage point gained represents women who will survive because their cancer was found when it could still be treated effectively.
Quick Facts
| Topic | Details |
|---|---|
| Early-Stage Diagnosis Rate (KATH) | 10.3% |
| Late-Stage Diagnosis Rate | 50% stage III, 39.3% stage IV |
| 5-Year Survival (Stage I) | 91% |
| 5-Year Survival (Stage IV) | 15% |
| Pooled Median Overall Survival | 4.4 years |
| Pooled 5-Year Survival | 46.5% |
| Average Symptom Duration Before Presentation | 10 months |
| Treatment Completion Without Abandonment | 18.5% |
| Cancer Medicine Availability | 14% in public hospitals |
| GBCI Early Detection Target | 60% |
Frequently Asked Questions
1. Why is early detection important for breast cancer in Ghana?
Early detection dramatically improves survival. In Ghana, 5-year survival is 91% for stage I disease but only 15% for stage IV. Most Ghanaian women are currently diagnosed at late stages, which is why early detection is critical .
2. What percentage of Ghanaian women are diagnosed early?
Only about 10.3% of patients at KATH were diagnosed with early-stage (I or II) breast cancer. Half were diagnosed at stage III and 39.3% at stage IV .
3. What is the 5-year survival rate for breast cancer in Ghana?
A 2026 meta-analysis found a pooled 5-year survival rate of 46.5% and a median overall survival of 4.4 years .
4. Why do Ghanaian women present late with breast cancer?
Common reasons include misconceptions about spiritual causes, fear and stigma, limited knowledge of symptoms, cost barriers, and cultural factors affecting access to screening .
5. What is the average delay before Ghanaian women seek care?
The average duration of symptoms before presentation is about 10 months .
6. Does the NHIS cover breast cancer treatment in Ghana?
The NHIS covers chemotherapy and radiotherapy for breast cancer. In 2026, breast screening was added to the Free Primary Healthcare package. However, patients still face out-of-pocket costs for some services .
7. Why do so many Ghanaian breast cancer patients abandon treatment?
The main reasons are cost and access. Cancer medicines are available in only 14% of public hospitals, forcing patients to pay out-of-pocket. Up to 86% of patients at KATH cannot complete treatment without interruption .
8. What is the Global Breast Cancer Initiative target for Ghana?
The GBCI targets diagnosing at least 60% of cases at an early stage. Ghana is currently at 10.3%, falling considerably short .
9. What can be done to improve early detection in Ghana?
Key actions include culturally tailored education, accessible screening at district levels, rapid referral systems, ensuring treatment completion, and engaging community and religious leaders .
10. Is breast self-examination effective for early detection?
Breast self-examination is a valuable tool when taught properly. A survey found 48.6% of rural women practised it, and it was closely associated with having been taught the technique (46.6%)
Source: Accra Street Journal
Last Updated on October 4, 2026 by Samuel Kwame Boadu
Disclaimer: Some content on Accra Street Journal may be aggregated, summarized, or edited from third-party sources for informational purposes. Images and media are used under fair use or royalty-free licenses. Accra Street Journal is a subsidiary of SamBoad Publishing Hub under SamBoad Business Group Ltd, registered in Ghana since 2014.
For concerns or inquiries, please visit our Privacy Policy or Contact Page.
Samuel Kwame Boadu is a Ghanaian media entrepreneur and storyteller with a passion for amplifying urban voices and uncovering everyday truths. He is the Editor-in-Chief and Founder of Accra Street Journal, a dynamic digital platform dedicated to capturing the pulse of Ghana’s capital—its people, culture, challenges, business, sports and innovations.
Use the following reference when citing or referencing this article.
Your feedback helps us improve our journalism.
Report an Error
Help us maintain accuracy. Let our editorial team know if you spot an issue in this article.





